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AntioxidantsAbstract Momordica dioica Roxb. Commonly known as ‘‘Kakora” in Telugu, is used in the Indian
traditional system of medicine for the treatment of diabetes. The aim of this study was to investigate
the antidiabetic activity of methanolic extract of M. dioica seeds (MEMD) in streptozotocin (STZ)
induced diabetic rats. The in vitro a-amylase inhibitory activity of the MEMD was done by
spectrophotometric method. Diabetes was induced by STZ (45 mg/kg; i.p), MEMD (100 &
200 mg/kg; b.wt) and standard drug metformin (50 mg/kg; b.wt) were administered to the diabetic
rats. Blood glucose was estimated on the 11th day and the level of MDA, SOD and CAT was
estimated in the liver tissue homogenate after the 15 days of experimental period. MEMD showed
significant inhibition of alpha amylase activity and the IC50 was found to be 48 lg/ml. Oral admin-
istration of MEMD significantly reduced blood glucose level (P< 0.05), diminished the MDA level
and refurbished depleted antioxidant enzymes and Insulin level to normalcy. These findings
revealed that M. dioica seeds possess antihyperglycemic, antioxidant and anti lipid peroxidative
activity and thus mitigate STZ-induced oxidative damage.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Globally, there is a rampant increase in people affected with
diabetes and pre-diabetes due to an array of clinical factors
like aging, smoking, unhealthy diet, hyperlipidemia and seden-
tary life style (Wild et al., 2004). Based on the report cited by
International Diabetes Federation, diabetes mellitus is the
mammoth cause of mortality and morbidity, with a projectedstrepto-
2 P.S. Rao, G.K. Mohanrange of 382 million adults being affected and 5.1 million peo-
ple killed in 2013. In 2035, the incidence of the disease is
ordained to be about 592 million, and the prevalence will be
higher in developing countries (Africa, Asia, and South Amer-
ica) with low and middle-incomes. Epidemiology studies reveal
that 80% of the global diabetes population is visualized in low
and middle income countries (International Diabetes
Federation, 2013). Diabetes is portrayed by minified glucose
homeostasis which may prelude to an elevated blood glucose
level with an alteration in lipid parameters (International
Diabetes Federation, 2013). Meanwhile, extended accumula-
tion of elevated blood glucose may lead to the overproduction
of reactive oxygen species accompanied with oxidative stress.
This noxious state may be involved in the progression of fatal
pathological event like atherosclerosis, cardiovascular disease
and other diabetic complications. Further, uncontrolled ele-
vated glucose level may impose a greater burden in the form
of restricted daily activity and work which result in high eco-
nomic costs (Jua´rez-Reyes et al., 2015).
Albeit, the allopathic medicines are currently used in the
management of diabetes mellitus, they exert serious adverse
effects and affect the quality of life (Aicher et al., 2010). Nowa-
days, herbal remedies are gaining more attention in the treat-
ment of a wide range of diseases as they have minimal
adverse effects. Thus, herbal medicines encompassing anti
hyperglycemic potential may serve as a suitable and safer alter-
native or as an adjunct candidate in the management of hyper-
glycemia. Ethnopharmacological reports authenticate that a
wide array of plants are used in folklore medicine for their pur-
ported anti-diabetic activity (Gupta et al., 2005a,b; Kesari
et al., 2005). The anti-diabetic efficacy in a wide range of plants
and plant products has been proved in various preclinical
models (Gupta et al., 2005a,b; Kesari et al., 2006; Mapanga
and Musabayane, 2010) as well as in human beings
(Jayawardena et al., 2005; Musabayane, 2012). In India, sev-
eral indigenous plant products have been used by practitioners
in the Ayurvedic system to treat hyperglycemia.
M. dioica Roxb. EX. Wild is a wild plant of the genus
Momordica. In folklore culture, M. dioica fruits, leaves, and
tuberous roots are used for the treatment of diabetes mellitus
in India (Sadyojatha and Vaidya, 1996). Previous preclinical
reports prove the anti diabetic activity and nephroprotective
properties of M. dioica (Gupta et al., 2011; Reddy et al.,
2006). However, there is a lack of credible evidence to reveal
the antidiabetic activity of M. dioica seeds. In this notion,
the present study entails the invitro anti amylase and antidia-
betic activity in streptozocin (STZ) induced hyperglycemic
rats.
2. Materials and methods
2.1. Plant extraction
Fresh fruits of M. dioica were collected locally, during July–
August, 2011 and seeds were removed mechanically and dried
under shade. They were identified and authenticated by Sri
Venkateshwara University, Botany department, Tirupati.
The seeds were powdered in an electric grinder. The coarse
powder was subjected to methanol extraction, in Soxhlet appa-
ratus and was run about 10 cycles. Then the resultant product
is filtered, dried in a desiccator and stored until further use.Please cite this article in press as: Rao, P.S., Mohan, G.K. In vitro alpha-amylase in
zotocin-induced oxidative stress in diabetic rats. Saudi Journal of Biological Science2.2. Chemicals and reagents
Streptozotocin was purchased from Sisco Research laborato-
ries Pvt Ltd. Acarbose was purchased from Glucobay, Bayer
Pharma, India. Metformin was a gift sample from Ranbaxy
Pvt ltd, Punjab, India. Other chemicals and reagents used in
the study were of high purity.
2.3. Preliminary phytochemical screening
MEMD was screened for the presence of various phytocon-
stituents like alkaloids, flavonoids, steroids, tannins, glyco-
sides, triterpenoids and saponins.
2.4. Invitro a-amylase inhibitory assay
The a-amylase inhibitory activity of MEMD was estimated by
the method of Bernfeld using Acarbose as the standard
(Bernfeld, 1955). Briefly a series of concentrations of MEMD
(10, 40 and 80 lg/ml) was prepared and allowed to react with
a-amylase and 2 mM of phosphate buffer (pH- 6.9). After incu-
bation for 20 min, to the reaction mixture 0.1 ml of 1% starch
solution was added. The same procedure was followed for con-
trol samples without the enzyme. Finally, 0.5 ml of dinitro sal-
icylic acid reagent was added to both control and test and kept
in a boiling water bath for 5 min. Then, the absorbance was
measured at 540 nm using spectrophotometer and the percent-
age inhibition was calculated using the formula,
ðAbsorbanceControlAbsorbanceTestÞ=ðAbsorbanceControlÞ1002.5. Animals
Male Wistar rats weighing about 150–200 g were obtained
from National Institute of Nutrition, Hyderabad. Animal Pro-
tocol was approved by IAEC (Institutional Animal Ethical
Committee) of CPCSEA (Committee for Purpose of Control
and Supervision of Experimentation on Animals) through its
reference no: IAEC/SVCP/2011/006, Dated: 26/7/11. Animals
were kept for acclimatization at an ambient temperature of 25
C and 45–55% relative humidity, with 12 h each of dark and
light cycles and were fed pelleted diet and water ad libitum.
2.6. Acute toxicity studies
The acute toxicity studies for MEMD were done according to
the OECD guidelines No. 423. The extract did not produce
any signs of toxicity when given in doses up to 2000 mg/kg
by an oral route. Hence, for further studies 100 & 200 mg/kg
dose of the extract were selected.
2.7. Streptozocin induced diabetes
A freshly prepared solution of STZ (45 mg/kg in 0.1 M citrate
buffer, pH 4.5) was injected intraperitonially to overnight-
fasted rats The rats exhibited hyperglycemia within 48 h of
STZ administration (Vogel et al., 2002). The rats having
fasting blood glucose (FBG) values of 250 mg/dl or above were
considered for the study.hibition and in vivo antioxidant potential of Momordica dioica seeds in strepto-
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Figure 1 Effect of methanolic extract of M. dioica (MEMD) on
in vitro a-amylase activity. The data are expressed as mean ± S.E.
M. n= 3 in each group.
Hypoglycemic effect of Momordica dioica seeds 32.8. Experimental design
The experiment was carried out in five groups of six rats each:
Group I- Normal control rats received saline.
Group II- Diabetic control.
Group III- Diabetic rats treated with standard drug,
Metformin (50 mg/kg).
Group IV- Diabetic rats treated with MEMD (100 mg/kg in
0.5% CMC).
Group V- Diabetic rats treated with MEMD (200 mg/kg
0.5% CMC).
At the end of the experimental period, the blood was
withdrawn by retro orbital puncture and centrifuged. Serum
glucose was estimated on the 11th day at 0 h, 1 h, 2 h and
4 h by Glucose oxidase method and the absorbance was mea-
sured at 505 nm by UV-Spectrophotometer (ELICO-Sl-159).
The fasting serum insulin was estimated by Maglumi auto ana-
lyzer (MAGLUMI 1000, Fully auto chemiluminescence
Immunoassay (CLIA) analyzer at Qedcure labs, Kukatpally,
Hyderabad (Hagino et al., 1994). On the 16th day animals
were sacrificed and the liver was removed and homogenized
for in vivo antioxidant activity study.
2.9. Preparation of liver homogenate
The liver was quickly removed and perfused immediately with
ice-cold saline (0.9% NaCl). A portion of the liver was homog-
enized in chilled Tris–HCl buffer (0.025 M, pH 7.4) using a
homogenizer. The homogenate obtained was centrifuged at
5000 rpm for 10 min, supernatant was collected and used for
various invivo antioxidant assays.
2.10. Invivo antioxidant activities
Lipid Peroxidation is based on the reaction of Malondialde-
hyde (MDA) one of the products of lipid peroxidation with
thiobarbituric acid to form Thiobarbituric acid reactive sub-
stances (TBARS), which have a pink color with absorption
maxima at 540 nm (Okhawa et al., 1979). Catalase (CAT)
activity was determined according to the method of Aebi
(1983). Superoxide dismutase (SOD) activity was determined
colorimetrically by the method of Kono (1978).
3. Statistical analysis
Results were expressed as mean ± S.E.M. For statistical
analysis of the data group, mean was compared by a one-
way analysis of variance (ANOVA) followed by Dunnett’s
test. p< 0.001 was considered to be statistically significant.
4. Results
4.1. Acute toxicity studies
Acute oral toxicity studies revealed the non toxic nature of
MEMD. There was no lethality observed nor any profound
toxic reactions found at a dose of 2000 mg/kg b.wt. p.o. which
indirectly pronounces the safety profile of the plant extract.Please cite this article in press as: Rao, P.S., Mohan, G.K. In vitro alpha-amylase in
zotocin-induced oxidative stress in diabetic rats. Saudi Journal of Biological Science4.2. Preliminary phytochemical analysis
Preliminary phytochemical analysis showed the presence of
alkaloids, flavanoids, steroids, tannins, glycosides, triter-
penoids and saponins in MEMD.
4.3. Effect of MEMD on a-amylase activity
In the present study, MEMD displayed a significant inhibition
a-amylase enzyme in a concentration dependent manner.
MEMD at the concentrations 10, 40 & 80 lg/ml elicited
11.33%, 42.6% and 75% of a-amylase enzyme inhibition
respectively. The IC50 value was found to be 48 lg/ml. Mean-
while, the standard compound Acarbose showed 6%, 27% and
80% of inhibition at the same concentration used in the test
and IC50 value was 35 lg/ml (Fig. 1).
4.4. Effect of MEMD on blood glucose and insulin levels
STZ intoxicated rats displayed a significant (p< 0.001)
elevation of blood glucose level in 0, 1, 2 & 4 h as compared
to the control rats. However oral administration of MEMD
(100 mg/kg) failed to diminish the blood glucose level in 1, 2
& 4 h as compared to the STZ rats (p> 0.05). While, in the
case of MEMD (200 mg/kg) a significant (p< 0.001) reduc-
tion in blood glucose level was observed in 1, 2 & 4 h as that
of diabetic induced rats (Table 2). Fasting insulin levels in
MEMD treated diabetic rats restored the levels significantly
(p< 0.0001) to normalcy as compared to diabetic control rats
(Table 1).
4.5. Effect of MEMD and STZ on lipid peroxidation
In the present study, STZ induced diabetic rats displayed a sig-
nificant (p< 0.001) elevation of MDA, a reliable marker lipid
peroxidation in the hepatic tissue homogenate, while, treat-
ment with MEMD (100 & 200 mg/kg) significantly
(p< 0.001) reduced the MDA level to normalcy (Fig. 2).
4.6. Effect of MEMD and STZ on antioxidants level in hepatic
tissue
The SOD and CAT levels were significantly (p< 0.001)
decreased in the liver of STZ induced diabetic rats. Oral intu-
bation of MEMD (200 mg/kg) significantly restored thehibition and in vivo antioxidant potential of Momordica dioica seeds in strepto-
s (2016), http://dx.doi.org/10.1016/j.sjbs.2016.01.010
Table 1 Effect of methanolic extract of M. dioica (MEMD) on blood glucose level in diabetic rats.
Treatment and dose 0 h 1 h 2 h 4 h
Control 94.4 ± 3.80 99.83 ± 3.01 108.5 ± 1.48 82.97 ± 0.85
Diabetic control 268.75 ± 5.5a 272.22 ± 3.95a 280.95 ± 3.26a 281 ± 4.78a
DC+MEMD (100) 290 ± 5.59 280 ± 4.72NS 272.6 ± 3.90NS 271.5 ± 3.80NS
DC+MEMD (200) 300.83 ± 12.34NS 204.66 ± 2.4a 173.33 ± 6.14a 161.66 ± 5.57a
DC+Metformin (50) 280.07 ± 15.36a 262.5 ± 8.54a 153.34 ± 2.48a 138.33 ± 1.82a
The data are expressed as mean ± S.E.M.; n= 6 in each group.
a p< 0.0001, highly significant, compared to diabetic control.
Table 2 Effect of methanolic extract of M. dioica (MEMD)
on serum insulin level in diabetic rats.
Treatment and dose Insulin levels (lIU/ml)
Control 7.74 ± 0.41
Diabetic control 3.50 ± 0.73a
DC+MEMD (100) 3.01 ± 0.36
DC+MEMD (200) 7.58 ± 0.72a
DC+Metformin (50) 10.67 ± 0.73a
The data are expressed as mean ± S.E.M. n= 6 in each group.
a p< 0.0001, highly significant, compared to diabetic control.
Figure 2 Effect of methanolic extract of M. dioica (MEMD) on
lipid peroxidation. The data are expressed in mean ± S.E.M.
n= 6 in each group p< 0.0001, highly significant, compared to
diabetic control.
Figure 3 Effect of methanolic extract of M. dioica (MEMD) on
antioxidant enzymes. The data are expressed as mean ± S.E.M.
n= 6 in each group. ap< 0.0001, highly significant, compared to
diabetic control. Units: CAT: U/mg of protein; SOD: lmoles/mg
of protein.
4 P.S. Rao, G.K. Mohandepleted (p< 0.001) antioxidant level to normalcy. MEMD
(100 mg/kg) doesn’t per se any significant effects on the
antioxidant level (Fig. 3).
5. Discussion
Diabetes mellitus is an alarming metabolic disorder leading to
hyperglycemia which later develops to micro- and macrovascu-
lar complications and becomes a major cause of death.
a-amylase is a digestive enzyme attached to the membrane of
brush border of the small intestine. It orchestrates a catalytic
conversion of complex carbohydrates complex carbohydrates
into monosaccharides that can be absorbed. Reduction of
postprandial hyperglycemia is the mainstay in the treatment
paradigm of diabetes mellitus. Blood glucose level reduction
can be confronted by extending the glucose absorption
through the downregulation of carbohydrate hydrolyzing
enzymes in the digestive tract. a-amylase inhibitors play aPlease cite this article in press as: Rao, P.S., Mohan, G.K. In vitro alpha-amylase in
zotocin-induced oxidative stress in diabetic rats. Saudi Journal of Biological Sciencepivotal role in blocking the release of glucose from dietary
source of carbohydrates and extend glucose absorption leading
to decreased postprandial plasma glucose levels and further
minify postprandial hyperglycemia (Lebovitz, 1997). Multi-
tude plant extracts and natural products decrease the glucose
production from carbohydrate in the gut or glucose absorption
from the intestine. In our study, MEMD effectively inhibited
the a-amylase activity invitro which is in line with a previous
report (Adisakwattana and Chanathong, 2011).
Streptozocin (STZ) is a noxious chemical agent used to
induce a state of hyperglycemia in preclinical models. The
mechanism of STZ induced diabetes is mainly due to the ram-
pant generation of reactive oxygen species (ROS), since STZ
intoxication causes rapid ATP dephosphorylation which may
lead to substrate availability for xanthine oxidase. So, these
series of toxic events lead to the generation of superoxide rad-
icals, hydrogen peroxide, and hydroxyl radicals and cause
oxidative pancreatic b-cell damage (Szkudelski, 2001). Fur-
ther, STZ causes selective pancreatic islet b-cell cytotoxicity
mediated through the release of nitric oxide (NO). This results
in a rapid reduction in pancreatic islet pyridine nucleotide con-
centration and subsequent b-cell necrosis (Haluzı´k and
Nedvı´dkova´, 2000). In the present study, STZ significantly
induced hyperglycemia and oral administration of MEMD
for a period of 10 days caused a significant decrease in blood
glucose levels. The promising mechanism by which MEMD
mediated its antidiabetic effect could be by potentiation of
pancreatic secretion of insulin from existing b-cells of islets,
as was evident by the significant increase in the level of insulin
in the extract treated animals.hibition and in vivo antioxidant potential of Momordica dioica seeds in strepto-
s (2016), http://dx.doi.org/10.1016/j.sjbs.2016.01.010
Hypoglycemic effect of Momordica dioica seeds 5In diabetes, tissue damage is considered to be mediated by
free radicals by attacking membranes through peroxidation of
unsaturated fatty acids (Ravi et al., 2004). Lipid peroxidation
eventually leads to extensive membrane damage and dysfunc-
tion (Alfy et al., 2005). The decreased lipid peroxidation and
improved antioxidant status may be one of the mechanisms
by which drug treatment could contribute to the prevention
of diabetic complications (Kamalakkannan and Prince,
2006). In our study, MEMD significantly attenuated the
increased lipid peroxidation which could be due to the antiox-
idant effect of flavonoids, detected in the preliminary phyto-
chemical screening of the extract.
The lipid peroxidation induced by diabetes displays a sub-
stantial decrease in the level of prime antioxidant enzymes like
SOD and CAT. These biomolecules have significant functions
in quenching the free radicals and dysfunctioning the toxic
adduct formation during the lipid peroxidation process. On
the other hand, the depleted level of antioxidant enzymes
may prelude to an elevated level of noxious superoxide anion
(O2
) and hydrogen peroxide in the vital tissues. These radicals
overture to release hydroxyl radicals, resulting in the initiation
and propagation of lipid peroxidation (Latha and Pari, 2003).
The MEMD treatment increased the activity of enzymes and
may thereby help to control free radicals. In this context, the
antidiabetic potential MEMD might be due to the effect of
bioactive principles present in the plant. Previous literature
highlights the isolation of isoflavone, daidzein in the fruit of
M. dioica (Kale and Laddha, 2012). Further, Momodi-
caursenol, an unknown pentacyclic triterpene was also
reported in the seeds of M. dioica (Ali and Srivastava 1998).
Thus, the antidiabetic activity of MEMD in the present study
might be due to the presence of these phytoconstituents.
In conclusion, the hypoglycemic action of M. dioica seeds
has beneficial effects on blood glucose level which might be
mediated through its a-amylase inhibitory activity. Mean-
while, lipid peroxidation was significantly reduced and the
level of endogenous antioxidant enzymes (CAT and SOD)
was boosted. Thus, the anti diabetic of M. dioica seeds might
be due to free radical scavenging and antioxidant activity. Fur-
ther, molecular studies and isolation of the active component
in the extract was highly warranted to elucidate the mechanism
of action of the plant.References
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